114041-77-9 Usage
Description
L-Alanine methyl ester is a chemical compound that consists of the amino acid L-alanine and a methyl ester group. It is known for its high stability and low toxicity, making it a valuable ingredient in various industrial applications.
Uses
Used in Pharmaceutical Industry:
L-Alanine methyl ester is used as a building block for the production of pharmaceuticals, contributing to the development of new drugs and medicines.
Used in Agrochemical Industry:
L-Alanine methyl ester is used as a building block for the production of agrochemicals, aiding in the creation of agricultural products and chemicals.
Used in Chemical Products Industry:
L-Alanine methyl ester is used as a building block for the production of other chemical products, enhancing the versatility and functionality of various chemical compounds.
Used in Peptide Synthesis:
L-Alanine methyl ester is used as a component in the synthesis of peptides, playing a crucial role in the formation of peptide bonds and the overall structure of peptides.
Used in Cell Culture Media:
L-Alanine methyl ester is used as a source of alanine for cell culture media, providing essential nutrients for cell growth and maintenance in laboratory and biotechnological applications.
Check Digit Verification of cas no
The CAS Registry Mumber 114041-77-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,0,4 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 114041-77:
(8*1)+(7*1)+(6*4)+(5*0)+(4*4)+(3*1)+(2*7)+(1*7)=79
79 % 10 = 9
So 114041-77-9 is a valid CAS Registry Number.
114041-77-9Relevant articles and documents
-
Tota,Elderfield
, p. 313,316 (1949)
-
Cytostatic thymine derivatives of 2-imidazolethione
Guglielmi
, p. 1733 - 1738 (1968)
-
Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
-
, (2008/06/13)
N-[1-oxo-(optionally 2-aza)-2-alkyl-3-(carboxyl or thiol or hydroxyaminocarbonyl or N-hydroxyformamido)-propyl]-(aryl or heteroaryl)-azacyclo4-7alkanes or thiazacyclo4-7alkanes, salts or prodrugs thereof have interesting properties, e.g., in the treatment or prevention of disorders amenable to treatment by PDF inhibitors, such as treatment of bacterial infections.